A compound heterozygote case of type II aldosterone synthase deficiency

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 6, 2003, Pages 2518-2526

  Dunlop, Felicity M ^a,e   Crock, Patricia A ^b   Montalto, Joseph ^c   Funder, John W ^a,d   Curnow, Kathleen M ^a,f  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c Dorevitch Pathology   (Australia)

^d HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^e Zenyth Therapeutics Limited Australia   (Australia)

^f Pharmacia Australia   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE SYNTHASE; AMINO ACID; CARBON; CHEMICAL COMPOUND; CYTOCHROME P450; STEROID;

ANIMAL CELL; ARTICLE; CASE REPORT; CATALYSIS; CELL STRAIN COS1; DIARRHEA; ENZYME STRUCTURE; ENZYME SUBSTRATE; EXON; FAILURE TO THRIVE; FEMALE; GENE MUTATION; GENE SEQUENCE; HETEROZYGOTE; HOSPITAL ADMISSION; HUMAN; HYPOALDOSTERONISM; HYPONATREMIA; INFANT; MOTHER; MUTANT; MUTATION; NONHUMAN; OXYGENATION; PRIORITY JOURNAL; STEROID BLOOD LEVEL; STEROID URINE LEVEL; VOMITING; WILD TYPE;

ANIMALIA;

EID: 0038305859     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-030353     Document Type: Article

References (33)

1. Peter M, Partsch CJ, Sippell WG 1995 Multisteroid analysis in children with terminal aldosterone biosynthesis defects. J Clin Endocrinol Metab 80:1622-1627
2. Yong AB, Montalto J, Pitt J, Oakes S, Preston T, Buchanan C 1994 Corticosterone methyl oxidase type II (CMO II) deficiency: biochemical approach to diagnosis. Clin Biochem 27:491-494
3. Lee PD, Patterson BD, Hintz RL, Rosenfeld RG 1986 Biochemical diagnosis and management of corticosterone methyl oxidase type II deficiency. J Clin Endocrinol Metab 62:225-229
4. Ulick S 1996 Correction of the nomenclature and mechanism of the aldosterone biosynthetic defects [Letter]. J Clin Endocrinol Metab 81:1299-1300
5. Portrat-Doyen S, Touniaire J, Richard O, Mulatero P, Aupetit-Faisant B, Curnow KM, Pascoe L, Morel Y 1998 Isolated aldosterone synthase deficiency caused by simultaneous E198D and V386A mutations in the CYP11B2 gene. J Clin Endocrinol Metab 83:4156-4161
6. Curnow KM, Tusie-Luna MT, Pascoe L, Natarajan R, Gu JL, Nadler JL, White PC 1991 The product of the CYP11B2 gene is required for aldosterone biosynthesis in the human adrenal cortex. Mol Endocrinol 5:1513-1522
7. Pascoe L, Curnow KM, Slutsker L, Rosler A, White PC 1992 Mutations in the human CYP11B2 (aldosterone synthase) gene causing corticosterone methyloxidase II deficiency. Proc Natl Acad Sci USA 89:4996-5000
8. Pascoe L, Curnow KM, Slutsker L, Connell JM, Speiser PW, New MI, White PC 1992 Glucocorticoid-suppressible hyperaldosteronism results from hybrid genes created by unequal crossovers between CYP11B1 and CYP11B2. Proc Natl Acad Sci USA 89:8327-8331
9. Pareckh RS, Flynn JT, Smoyer WE, Milne JL, Kershaw DB, Bunchman TE, Sedman AB 2001 Improved growth in young children with severe chronic renal insufficiency who use specified nutritional therapy [Erratum: J Am Soc Nephrol 12:2418-26, 2002]. J Am Soc Nephrol 13:1421-1422
10. Peter M, Bunger K, Solyom J, Sippell WG 1998 Mutation THR-185 ILE is associated with corticosterone methyl oxidase deficiency type II. Eur J Pediatr 157:378-381
11. Hauffa BP, Solyom J, Glatz E, Shackleton CH, Wambach G, Vecsei P, Stolecke H, Homoki J 1991 Severe hypoaldosteronism due to corticosterone methyl oxidase type II deficiency in two boys: metabolic and gas chromatography-mass spectrometry studies. Eur J Pediatr 150:149-153
12. Peter M, Nikischin W, Heinz-Erian P, Fussenegger W, Kapelari K, Sippell WG 1998 Homozygous deletion of arginine-173 in the CYP11B2 gene in a girl with congenital hypoaldosteronism. Corticosterone methyloxidase deficiency type II. Horm Res 50:222-225
13. Zhang G, Rodriguez H, Pardella CE, Harris DA, Miller WL 1995 Mutation T318M in the CYP11B2 gene encoding P450c11AS (aldosterone synthase) causes corticosterone methyl oxidase II deficiency. Am J Hum Genet 57:1037-1043
14. Gomez-Sanchez CE, Foecking MF, Ferris MW, Ghavarri MR, Uribe L, Gomez-Sanchez EP 1987 The production of monoclonal antibodies against aldosterone. Steroids 49:581-587
15. Zuber MX, Mason I, Simpson ER, Waterman MR 1988 Simultaneous transfection of COS-1 cells with mitochondrial and microsomal steroid hydroxylases: incorporation of a steroidogenic pathway into nonsteroidogenic cells. Proc Natl Acad Sci USA 85:699-703
16. Skinner CA, Rumsby G, Honour JW 1996 Single strand conformation polymorphism (SSCP) analysis for the detection of mutations in the CYP11B1 gene. J Clin Endocrinol Metab 81:2389-2393
17. Loidi L, Quinteiro C, Dominguez F, Barreiro J, Pombo M 1999 The C494F variant in the CYP11B1 gene is a sequence polymorphism in the Spanish population. J Clin Endocrinol Metab 84:4749
18. Rumsby G 1999 Single-strand conformation polymorphism analysis for the detection of mutations in the CYP11B1 gene. J Clin Endocrinol Metab 84:4749
19. 320Ala convert the cortisol producing enzyme, CYP11B1, into an aldosterone producing enzyme [Letter]. Nat Struct Biol 4:32-35
20. Bottner, B, Denner K, Bernhardt R 1998 Conferring aldosterone synthesis to human CYP11B1 by replacing key amino acid residues with CYP11B2-specific ones. Eur J Biochem 252:458-466
21. Graham SE, Peterson JA 1999 How similar are P450s and what can their differences teach us? Arch Biochem Biophys 369:24-29
22. Graham-Lorence SE, Peterson JA 1996 Structural alignments of P450s and extrapolations to the unknown. Methods Enzymol 272:315-326
23. Lewis DF, Lee-Robichaud P 1998 Molecular modelling of steroidogenic cytochromes P450 from families CYP11, CYP17, CYP19 and CYP21 based on the CYP102 crystal structure. J Steroid Biochem Moi Biol 66:217-233
24. Mitsuuchi T, et al. 1993 Congenitally defective aldosterone biosynthesis in humans: inactivation of the P450c18 gene (CYP11B2) due to nucleotide deletion in CMO I deficient patients. Biochem Biophys Res Commun 190:864-869
25. Peter M, et al. 1997 Hereditary defect in biosynthesis of aldosterone: aldosterone synthase deficiency 1964-1997. J Clin Endocrinol Metab 82:3525-3528
26. Peter M, et al. 1998 Molecular genetic study in two patients with congenital hypoaldosteronism (types I and II) in relation to previously published hormonal studies. Eur J Endocrinol 139:96-100
27. Geley S, et al. 1995 Amino acid substitution R384P in aldosterone synthase causes corticosterone methyloxidase type I deficiency. J Clin Endocrinol Metab 80:424-429
28. Nomoto S, et al. 1997 CMO I deficiency caused by a point mutation in exon 8 of the human CYP11B2 gene encoding steroid 18-hydroxylase (P450C18). Biochem Biophys Res Commun 234:382-385
29. Kayes-Wandover KM, et al. 2001 Type I aldosterone synthase deficiency presenting in a middle-aged man. J Clin Endocrinol Metab 86:1008-1012
30. Lopez-Siguero JP, et al. 1999 Aldosterone synthase deficiency type I: hormonal and genetic analyses of two cases. Horm Res 52:298-300
31. Wasniewska M, et al. 2001 Aldosterone synthase deficiency type I with no documented homozygous mutations in the CYP11B2 gene. Eor J Endocrinol 144:59-62
32. Mitsuuchi Y, et al. 1992 Congenitally defective aldosterone biosynthesis in humans: the involvement of point mutations of the P450C18 gene (CYP11B2) in CMO II deficient patients [published erratum appears in Biochem Biophys Res Commun 1992, 184(3):1529-30]. Biochem Biophys Res Commun 182:974-979
33. Fardella CE, et al. 1996 Gene conversion in the CYP11B2 gene encoding P450c11AS is associated with, but does not cause, the syndrome of corticosterone methyloxidase II deficiency. J Clin Endocrinol Metab 81:321-326